TNBC Clinical Trials

17 clinical trials for TNBC across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer — RECRUITING · PHASE2
• A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer. — RECRUITING · NA
• Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases — RECRUITING · PHASE2
• A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• HS-10502 Combination Treatment in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration — RECRUITING
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer — NOT_YET_RECRUITING · PHASE2
• An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC) — OTHER
• A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer — NOT_YET_RECRUITING · NA
• A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation — NOT_YET_RECRUITING · PHASE2
• Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients — NOT_YET_RECRUITING · PHASE3
• A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer — NOT_YET_RECRUITING · PHASE2
• SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases — OTHER · PHASE2

Refine this search